信義玻璃(00868.HK)預期中期純利減少55%至65%
格隆匯7月18日丨信義玻璃(00868.HK)公告,截至2025年6月30日止六個月,公司權益持有人應佔的綜合純利金額預期較2024年上半年的純利人民幣25.093億元減少55%至65%。
2025年上半年純利金額的預期減少乃主要由於以下原因:(1)於2025年上半年,集團浮法玻璃業務的收益及毛利較2024年上半年持續下降,乃由於(a)中國新建物業項目數量大幅下降;(b)浮法玻璃產品需求疲弱;及(c)中國浮法玻璃產品的市場價格受壓制;(2)於2025年上半年,應佔公司聯營公司信義光能控股有限公司的溢利減少;及(3)集團於中國的閒置生產設施所產生的減值虧損金額及集團於中國若幹生產設施的處置損失金額增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.